| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |